SEC Form 4 · accession 0001654954-18-002932
CorMedix Inc. · CRMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Janet Dillione
Director
Period of report
Feb 21, 2018
Accepted (ET)
Mar 22, 2018 · 4:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001410098
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 21, 2018 | M | 15,357 | $0.00 | A | 107,409 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1 | $0.00 | Feb 21, 2018 | M | 15,357 | D | — | — | Common Stock | 15,357 | 0 | D |
| Stock Option (Right to Buy Common Stock)F2 | $0.57 | holding | — | — | — | — | Feb 16, 2028 | Common Stock | 40,000 | 40,000 | D |
| Restricted Stock UnitsF3 | — | holding | — | — | — | — | — | Common Stock | 10,000 | 10,000 | D |
| Restricted Stock UnitsF3 | — | holding | — | — | — | — | — | Common Stock | 4,000 | 4,000 | D |
| Phantom StockF4 | — | holding | — | — | — | — | — | Common Stock | 13,392 | 13,392 | D |
| Phantom StockF4 | — | holding | — | — | — | — | — | Common Stock | 15,625 | 15,625 | D |
| Phantom StockF4 | — | holding | — | — | — | — | — | Common Stock | 20,833 | 20,833 | D |
| Stock Option (Right to Buy Common Stock)F5 | $2.24 | holding | — | — | — | — | Feb 21, 2027 | Common Stock | 40,000 | 40,000 | D |
| Phantom StockF4 | — | holding | — | — | — | — | — | Common Stock | 3,472 | 3,472 | D |
| Phantom StockF4 | — | holding | — | — | — | — | — | Common Stock | 4,143 | 4,143 | D |
| Stock Option (Right to Buy Common Stock)F6 | $3.03 | holding | — | — | — | — | Aug 11, 2025 | Common Stock | 50,000 | 50,000 | D |
| Phantom StockF4 | — | holding | — | — | — | — | — | Common Stock | 1,415 | 1,415 | D |
| Stock Option (Right to Buy Common Stock)F7 | $1.91 | holding | — | — | — | — | Feb 21, 2026 | Common Stock | 95,000 | 95,000 | D |
| Phantom StockF4 | — | holding | — | — | — | — | — | Common Stock | 3,831 | 3,831 | D |
| Phantom StockF4 | — | holding | — | — | — | — | — | Common Stock | 2,767 | 2,767 | D |
| Phantom StockF4 | — | holding | — | — | — | — | — | Common Stock | 4,335 | 4,335 | D |
| Phantom StockF4 | — | holding | — | — | — | — | — | Common Stock | 15,306 | 15,306 | D |
Explanation of responses
- F1These Restricted Stock Units were granted on 2/21/2017. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock vested in full on the first anniversary of the date of grant, which was February 21, 2018.
- F2These options were granted on 2/16/2018. These options vest in full on the first anniversary of the date of grant, subject to continued service on the board.
- F3These Restricted Stock Units were granted on 2/16/2018. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock vests in full on the first anniversary of the date of grant, subject to continued service on the board.
- F4Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a director.
- F5These options were granted on 2/21/2017. The options vest in full on the first anniversary of the date of grant, subject to continued service on the board.
- F6These options were granted on 8/12/2015. The options vest as follows: 1/3 on 8/12/2015, 1/3 on 8/12/2016, and 1/3 on 8/12/2017.
- F7These options were granted on 2/21/2016. These options vest in full on the first anniversary of the date of grant, subject to continued service on the board.